Cel Sci's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Cel Sci in the third quarter 2026?
Cel Sci Corporation recorded a cumulative net loss of $-11 million during 12 months ending in the third quarter 2026, resulting in a negative return on equity (ROE) of -91.41%.

Within the Biotechnology & Pharmaceuticals industry 73 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 3759, from total ROE ranking in the second quarter 2026 at 4371.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter
Y / Y Equity Change	55.96 %	-14.04 %	24.01 %	24.01 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-11	-23	-24	-25	-25
Return On Equity (TTM)	-91.41 %	-198.2 %	-202.89 %	-231.82 %	-243 %
CVM's Total Ranking	# 3759	# 4371	# 3843	# 3920	# 3995
Equity (TTM) in Millions	11	7	16	16	7
Seq. Equity Change	59.36 %	-56.92 %	0 %	127.15 %	-12.16 %
Seq. Net Income Change	-	-	-	-	-

Back to CVM Management Effectiveness >> CVM's 5 Years Annual ROE >> Compare CVM ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 74
Sector	# 535
Overall	# 3759

Return On Equity Statistics
High	Average	Low
-25.96 %	-394.33 %	-6127.91 %
(Jun 30 2023)		(Jun 30 2019)

CVM Annual Return On Equity	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021
Total Equity in Millions	16	13	13	32	57
Y / Y Equity Change	24.01 %	-2.63 %	-58.91 %	-43.11 %	186.59 %
Net Income in Millions	-25	-27	-32	-38	-37
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-159.25 %	-209.22 %	-244.92 %	-117 %	-64.94 %

Back to CVM Management Effectiveness >> CVM's 5 Years Annual ROE >> Compare CVM ROE to its Competitors

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CVM's' Return on Equity at Yahoo Finance
CVM's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CVM's Competitors
Subscribers only: Roe for Cel Sci's Suppliers
Subscribers only: Return On Equity for CVM's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector

ROE

Date modified: 2026-09-12T06:11:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.